Activated charcoal administration in a pediatric emergency department
Related Experiment Video
Updated: Aug 23, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Kevin C Osterhoudt1, Elizabeth R Alpern, Dennis Durbin
1Section of Medical Toxicology, Division of Emergency Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Osterhoudtk@email.chop.edu
Insights
Activated charcoal (AC) is frequently used for pediatric poisoning, but rarely administered within 1 hour of ingestion. Flavoring agents do not improve AC palatability or administration success.
Area of Science:
- Pediatric Emergency Medicine
- Toxicology
- Gastrointestinal Decontamination
Background:
- Activated charcoal (AC) is a common gastrointestinal decontamination method in US pediatric emergency departments.
- Current practice regarding AC administration timing, route, and adjuncts requires detailed description.
Purpose of the Study:
- To describe the practice of single-dose activated charcoal administration in a pediatric emergency department.
- To analyze timing relative to ingestion and presentation, route of administration, use of flavoring agents, and adverse events.
Main Methods:
- Prospective collection of descriptive data on consecutive AC administrations.
- Study conducted in an urban, academic pediatric emergency department over 2.5 years.
Main Results:
- 7.8% of children received AC within 1 hour of poisoning exposure, despite 55% receiving it within 1 hour of ED arrival.
- Oral administration success varied by age, with 32% of young children refusing or being intolerant.
- Flavoring agents did not improve palatability; one case of pulmonary aspiration and one of constipation were reported.
Conclusions:
- AC administration in pediatric emergency departments often falls outside recommended timeframes post-ingestion.
- Gastric tube use is age-dependent and subjective; flavoring agents offer no proven benefit.
- Pulmonary aspiration and constipation are potential risks associated with AC therapy.
Objectives:
Activated charcoal is the commonest form of gastrointestinal decontamination offered to potentially poisoned children within United States emergency departments. Our aim was to describe this practice with regard to timing, route of administration, use of flavoring agents, and occurrence of adverse events other than vomiting.
Methods:
Descriptive data were prospectively collected from consecutive administrations of single-dose activated charcoal, within an urban, academic pediatric emergency department, over a period of 2.5 years.
Results:
Two hundred seventy-five subjects were enrolled. The median time elapsed between ingestion and emergency department arrival was 1.2 hours. Although 55% of children were administered charcoal within 1 hour of emergency department presentation, only 7.8% received charcoal within 1 hour of poisoning exposure. Forty-four percent of children younger than 6 years, 50% of 6-year to 12-year olds, and 89% of 12-year to 18-year olds drank the charcoal voluntarily (P < 0.01). Medical staff chose not to offer charcoal orally to 42 asymptomatic children among the 176 subjects under the age of 6 years. Of the 114 young children offered oral charcoal, 36 (32%) refused or were intolerant. Nurses added flavoring agents to the charcoal in 59% of oral administrations, but this act did not enhance observed palatability. Among children younger than 6 years, the median time from first sip to complete ingestion of charcoal slurry was 15 minutes. One pulmonary aspiration event and a case of constipation were noted.
Conclusions:
Despite published guidelines, children treated in an emergency department rarely received charcoal within 1 hour of ingestion. Gastric tube administration of charcoal varies by age and is partly subjective in its application. We found no evidence that excipient flavoring of charcoal improved success of administration. Pulmonary aspiration of charcoal, although uncommon, should be considered when assessing the risk of therapy. We offer a report of symptomatic constipation from single-dose charcoal.
Related Concept Videos
Prevention of Further Absorption of Poison
Pharmaceutical Poisoning: Treatment Strategies
Cardiopulmonary Resuscitation II: ACLS Airway Management
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiopulmonary Resuscitation III: AED Use
